Diagnosis of autoimmune hepatitis;Diagnostik der Autoimmunhepatitis

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 48, 1996, Pages 1503-1507

  Manns, M P ^a   Rambusch, E G ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

AUTOIMMUNE HEPATITIS; DIFFERENTIAL DIAGNOSIS; GENETIC MARKER; HUMAN; SEROLOGY; SHORT SURVEY;

EID: 0029821067     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024052     Document Type: Short Survey

References (27)

1. Aaltonen, J., P. Bforses, L. Sadkuijl, J. Pereentupa, L. Peltonen: An autosomal locus causing autoimmune disease. Autoimmune polyglandular disease type 1 assigned to chromosome 21. Nature Genet. 8 (1994), 83-87.
2. Ahonen, P., S. Myllärniemi, I. Sipilä, J. Perheentupa: Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. New Engl. J. Med. 322 (1990), 1829-1836.
3. Czaja, A. J., H. A. Carptenter, M. P. Manns: Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology 105 (1993), 1522-1528.
4. Czaja, A. J., H. A. Carptenter, P. J. Santrach, S. B. Moore: Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 105 (1993), 1502-1507.
5. Czaja, A. J., M. P. Manns: The validity and importance of subtypes in autoimmune hepatitis. A point of view. Amer. J. Gastroent. 90 (1995), 1206-1211.
6. Czaja, A. J., M. P. Mannss, H. A. Homburger: Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 103 (1992), 1290 - 1295.
7. Czaja, A. J., J. Rakela, J. E. Hay, S. B. Moore: Clinical and prognostic implications of human leukocyte antigen B8 in cortiosteroid-treated severe autoimmune chronic active hepatitis. Gastroenterology 98 (1990), 1587-1593.
8. Desmet, V. J., M. Gerber, J. H. Hoofnagle, M. Manns, P. J. Scheuer: Classification of chronic hepatitis. Diagnosis, grading and staging. Hepatology 19 (1994), 1513-1520.
9. Durazzo, M., T. Philipp, F. N. A. M. Van Pelt, B. Lüttig, E. Borghese, G. Michel, E. Schmidt, S. Loges, M. Rizetto, M. P. Manns: Heterogeneity of microsomal autoantibodies (LKM) in chronic hepatitis C and D virus infection. Gastroenterology 108 (1995), 455-462.
10. Heringlake, S., H. L. Tillmann, P. Cordes-Temme, C. Trautwein, G. Hunsmann, M. P. Manns: GBV-C is not the major cause of autoimmune hepatitis. J. Hepatol., in press.
11. Homberg, J.-C., N. Abuaf, O. Bernard, S. Islam, S. H. Alavarez, R. Poupon, F. Darnis, V.-G. Levy, P. Grippon, P. Opulon, J. Bernuau, F.-P. Benhamou, D. Agagille: Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1. A second type of »autoimmune« hepatitis. Hepatology 19 (1987), 1333-1339.
12. Johnson, P. J., I. G. McFarlane: Meeting report of the International Autoimmune Hepatitis Group. Hepatology 18 (1993), 998-1005.
13. Joplin, R., J. G. Lindsay, G. D. Johnson, A. Strain, J. Neuberger: Membrane dihydrolipoamide acetyltransferase (E 2) in human biliary epithelial cells in primary biliary cirrhosis. Lancet 339 (1992), 93-94.
14. Kurki, P.: Cytosceleton antibodies in chronic active hepatitis. In Meyer zum Büschenfelde, K.-H., J. Hoofnagle, M. P. Manns (Ed.): Immunology and Liver (Kluwer: Dordrecht 1993), 206-214.
15. Linnen, J., J. Wages jr., Z. Y. Zhang-Keck, K. E. Fry, K. Z. Krawczynski, H. Alter, E. Koonin, M. Gallagher, M. Alter, S. Hadziyannis, P. Karayiannis, K. Fung, Y. Nakatsuji, J. Wai-Kuo Shih, L. Young, M. Piatak jr., C. Hoover, J. Fernandez, S. Chen, J. Chao Zou, T. Morris, K. C. Hyams, S. Ismay, J. D. Lifson, G. Hess, S. K. H. Foung, H. Thomas, D. Bradley, H. Margolis, J. P. Kim †: Molecular cloning and disease association of hepatitis G virus. A transfusions-transmissionable agent. Science 271 (1996), 508-508.
16. Lunel, F., N. Abuaf, L. Frangeul, P. Grippon, M. Perrin, Y. Le Coz, D. Valla, E. Borotto, A.-M. Yamamoto, L.-M. Huraux, P. Opolon, J.-C. Homberg: Liver/kidney microsomes antibody type 1 and hepatitis C virus infection. Hepatology 16 (1992), 630-636.
17. Manns, M. P., G. Gerken, A. Kyriatsoulis, M. Staritz, K.-H. Meyer zum Büschenfelde: Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against soluble liver antigen. Lancet 1987/I, 292-294.
18. Manns, M. P., K. J. Griffin, K. F. Sullivan, E. F. Johnson: LKM-1 autoantibodies recognize a short linear sequence in P450 II D6, a cytochrome P450 monooxygenase. J. clin. Invest. 88 (1991), 1370-1378.
19. McFarlance, I. G., B. M. McFarlane, G. N. Major, P. Tolley, R. Williams: Identification of the hepatic asialoglycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP). Clin. exp. Immunol. 55 (1985), 347-354.
20. Michel, G., A. Ritter, G. Gerken, K.-H. Meyer zum Büschenfelde, R. Decker, M. P. Manns: Anti-GOR and hepatitis C virus in autoimmune liver disease. Lancet 339 (1992), 267-269.
21. Nishioka, M.: Nuclear antigens in autoimmune hepatitis. In Meyer zum Büschenfelde, K.-H., J. Hoofnagle, M. P. Manns (Ed.): Immunology and Liver (Kluwer: Dordrecht 1993), 193-205.
22. Philipp, T., M. Durazzo, C. Trautwein, B. Alex, P. Sträub, G. Lamb, E. F. Johnson, R. H, Tukey, M. P. Manns: Recognition of uridine diphosphorylglucuronosyltransferase by LKM-3 autoantibodies in chronic hepatitis D. Lancet 344 (1994), 578-581.
23. Simons, J. N., T. P. Leary, G. J. Dawson, T. J. Pilot-Matias, A. J. Muerhof, G. G. Schlauder, S. M. Desai, I. K. Mushahwar: Isolation of novel virus like sequences associated with human hepatitis. Nature Med. 1 (1995), 564-569.
24. Stechemesser, E., R. Klein, P. A. Berg: Characteriziation and clinical relevance of liver-pancreas antibodies in autoimmune active hepatitis. Hepatology 18 (1993), 1-9.
25. Stechemesser, E., J. Strienz, P. A. Berg: Serological definition of a new subgroup of patients with autoimmune chronic active hepatitis. Lancet 1987/I, 683.
26. Tillmann, H. L., B. Michitaka, B. Rodeck, J. Brodehl, R. Pichlmayr, M. Manns: Fulminant hepatic failure in autoimmune hepatitis type 2 with markers of acute herpes simplex virus infection. Falk Symposium No. 70: Immunologie und Leber (Basel 1992), Abstract 175.
27. Van Pelt, F. N. A. M., P. Straub, M. P. Manns: Molecular basis of drug-induced immunological liver injury. Semin. Liver Dis. 15 (1995), 283-300.